Baseline Repeated Measures from Controlled Human Exposure Studies: Associations between Ambient Air Pollution Exposure and the Systemic Inflammatory Biomarkers IL-6 and Fibrinogen

1The association between air pollution and cardiovascular morbidity and mortality is supported by epidemiologic and experimental evidence. Systemic inflammation may be one of the potential mechanisms mediating the effect of air pollution on cardiovascular outcomes.

2Elevated systemic levels of interleukin-6 (IL-6) have been demonstrated to be an independent risk factor for cardiovascular morbidity and mortality. IL-6 also stimulates the production of acute-phase proteins, including C-reactive protein (CRP), which can predict cardiovascular risk. The literature documents pollutant-associated elevations in pulmonary IL-6 in healthy subjects (in vivo) and tissue (in vitro) and pollutant-associated elevations in systemic IL-6 in subjects with preexisting chronic inflammatory conditions, although this association has not been demonstrated in young, healthy subjects.

3Similar to IL-6, elevated levels of fibrinogen have been shown to be an independent risk factor for cardiovascular disease and have also been hypothesized to be associated with air pollution. This hypothesis is supported by literature considering air pollution and disturbances in hemostasis in general, although studies considering the specific association between air pollutants and fibrinogen report conflicting results.

4Human exposure studies aim to determine the biological effects of air pollutants by using controlled levels of pollutants coupled with an extensive exposure characterization and detailed measurements of physiologic outcomes. For example, controlled human exposure studies using fine concentrated ambient particles (CAPs) have demonstrated changes in biomarkers associated with systemic inflammation, including IL-6 and fibrinogen.

5In this study we investigated the association between ambient air pollution and inflammatory markers using baseline data from chamber study exposures. We considered the effects of ozone, nitrogen dioxide, sulfur dioxide, and particulate matter ≤ 2.5 μm in aerodynamic diameter (PM2.5) on IL-6 and fibrinogen, using single-pollutant models to analyze repeated-measures data in a group of healthy subjects. We investigated the temporal association between exposure to the pollutants and changes in IL-6 and fibrinogen using moving averages up to 7 days.

6In addition to addressing the question of what effect, if any, ambient air pollution exposure has on the baseline levels of IL-6 and fibrinogen, the findings of this study may have additional relevance to the interpretation of human chamber exposure studies: If ambient pollution exposure significantly effects subjects’ baseline inflammatory markers, then pollutant exposure before controlled human exposure studies including CAPs may modify subjects’ inflammatory responses. Before investigating possible effect modification by ambient pollution exposure on human chamber exposure study outcomes, it is first necessary to address what effect, if any, ambient pollution exposure has on subjects’ baseline inflammatory markers, and this was the primary goal of this study.

7The study population consisted of 45 adults 18–40 years of age who participated in one of two studies conducted in Toronto, Ontario, Canada, between 14 July 1999 and 25 February 2003 (study A) and between 8 January 2004 and 27 March 2006 (study B) and who had IL-6 and fibrinogen measurements at baseline before human chamber exposure to air pollution. Exclusion criteria common to both studies were based on clinical situations or drugs that had the potential to alter systemic inflammation and vascular reactivity. Subjects were excluded if they had a history of coronary artery disease, previous myocardial infarction, peripheral vascular disease, angina, heart failure, or atherosclerosis or used any medications associated with cardiovascular disorders. For the asthmatic participants (n = 10), additional exclusion criteria were a forced vital capacity or forced expiratory volume in 1 sec of < 75% of the predicted normal value, or use of oral medications or inhaled corticosteroids for asthma. Bronchodilators were withheld from midnight before each visit. Subjects were also requested to refrain from taking any vitamins or over-the-counter preparations in the 48 hr before each visit.

8We conducted a retrospective analysis using repeated-measures data collected as part of two controlled human exposure investigations. The data used in this study consisted of the baseline measurements taken before subjects entered the exposure chamber. Height and weight measurements were taken during the initial visit. Blood draws were conducted at 1000 hours on the day of each visit for all participants. All visits were in random order and separated by at least 2 weeks.

9This study was approved by the St. Michael’s Hospital Research Ethics Board. The studies from which data were derived complied with relevant research ethics guidelines as well as the Ontario Personal Health Information Act. Human participants gave written informed consent before enrollment in the study.

10Venous blood was collected in EDTA tubes for IL-6 and sodium citrate tubes for fibrinogen. Samples were centrifuged, and the resulting plasma samples were stored at –70°C until analysis. Depending on the study for which the sample was drawn, samples were analyzed for IL-6 using either commercial high- sensitivity enzyme-linked immunosorbent assay (ELISA; Amersham Pharmacia, Little Chalfont, Buckinghamshire, UK) or the multiplex Luminex bead assay method (Luminex, Austin, TX, USA). Fibrinogen concentration was determined quantitatively based on the Clauss clotting method (MLA 1600; Medical Laboratory Automation, Pleasantville, NY, USA).

11Hourly ambient pollutant data (O3, NO2, SO2, and PM2.5) were obtained from an Ontario Ministry of the Environment fixed-site air-monitoring station located in downtown Toronto. Hourly temperature and humidity data, collected at a fixed-site air-monitoring station at Pearson International Airport in Toronto, were provided by Environment Canada.

12We conducted univariate explorations for all variables using histograms, linear graphing techniques, and summary statistics. We calculated Spearman correlation coefficients for the pollutant and meteorologic data to investigate the relationships among these variables over the study period. The associations between the inflammatory markers, IL-6 and fibrinogen, and the pollutants, O3, NO2, SO2, and PM2.5, were analyzed using linear mixed-effects models with random patient intercepts to account for repeated measures. Date, day of the week, season, and 24-hr moving averages for relative humidity and temperature were included in the models as time-varying confounders based on goodness-of-fit as determined using Akaike’s information criterion. Age, sex, body mass index (BMI), and asthmatic status were included as time-invariant participant characteristics associated with the mean levels of the inflammatory markers to permit the assumption of a normally distributed random patient intercept. Age and date were included in the models as linear variables. We considered data for each of the pollutants at the time of blood draw (baseline) along with the 2-, 4-, 6-, and 12-hr and 1- to 7-day moving averages of the pollutants. We assessed effect modification using an interaction term in the models while also including the main effects of season and pollution. The interaction term consisted of a four-level categorical term for season multiplied by the pollutant being analyzed.

13IL-6 data from each study were not directly comparable because study A analyzed samples using ELISA plates whereas study B used the Luminex bead assay system. To allow compilation of the IL-6 data into a single data set, the data were transformed to standard scores (Z-scores). As a result, effect estimates for IL-6 are presented as the linear change in the SD of IL-6 per each pollutant’s interquartile range (IQR). Fibrinogen levels were measured using the same techniques in both studies, so effect estimates for fibrinogen are presented as the linear increase in fibrinogen (grams per liter) per each pollutant’s IQR.

14Data were analyzed using the statistical package SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).

15The study population consisted of 45 participants (22 males, 23 females) with a mean of 3.9 (range, 1–6) repeated blood samples, mean age of 26.6 years (range, 19–48 years), and mean BMI of 22.7 (range, 17.8–29.9). Ten of the 45 subjects had a history of well-controlled asthma.

16Table 1 displays summary data on the inflammatory markers by study and participant characteristics. A total of 163 samples of IL-6 and 160 samples of fibrinogen were available for analysis. IL-6 and fibrinogen were moderately correlated (Spearman correlation coefficient = 0.21, p = 0.01).

17The mean (range) meteorologic and pollutant data were as follows: temperature, 9.2°C (–24.6 to 37.2°C); relative humidity, 69.6% (15–100%); O3, 21.9 ppb (0–136 ppb); NO2, 23.8 ppb (0–106 ppb); SO2, 3.5 ppb (0–70 ppb); carbon monoxide, 0.7 ppm (0–4 ppm); and PM2.5, 8.5 μg/m3 (0–140 μg/m3). These levels are comparable to those reported for major cities in Europe and the United States. Table 2 displays the meteorologic and pollutant data stratified by season.

18Table 3 displays correlations for the pollutants and meteorologic parameters. We observed significant correlations among NO2, SO2, CO, and PM2.5. NO2, SO2, and CO were negatively correlated with O3.

19IL-6 was positively correlated with each of the pollutants investigated and reached statistical significance at the 95% level with O3 and SO2 (Figure 1). Associations increased with longer moving averages, with statistical significance being reached with the 1- to 6-day moving average for O3 and the 4- and 5-day moving average for SO2. We observed similar trends for NO2 and PM2.5. We observed the strongest association between IL-6 and O3 using the 4-day moving average: a 0.31 SD increase in IL-6 per O3 IQR [95% confidence interval (CI), 0.08–0.54]. The 4-day moving average for SO2 showed a 0.25 SD increase in IL-6 per SO2 IQR (95% CI, 0.06–0.43). The positive association between IL-6 and each pollutant declined with moving averages longer than 6 days. Fibrinogen was not significantly correlated with any of the pollutants investigated, and we found no trend for increasing moving averages (Figure 2).

20Pollution associations with level of IL-6 varied by season, with higher effects of O3 on IL-6 in the spring and summer and higher effects of PM2.5 in the summer. NO2 associations with IL-6 were elevated both in summer (marginally) and in winter. The significance of the effect modification increased with moving averages up to 3 days, with the strongest effects occurring using 2-day moving averages (Figure 3). We observed no effect modification by season for fibrinogen and the investigated pollutants.

21In measurements taken before controlled chamber exposure to pollution, study participants had elevated systemic levels of IL-6 in response to elevations in the previous 4-day cumulative averages of ambient O3 and SO2 levels. IL-6 responses tended to be higher in the spring and summer for O3 and in the summer for PM2.5. In Toronto these are seasons when open windows may allow more penetration of O3 and when mixtures of O3 and particulate pollution may be more prominent.

22The observed correlations for the pollutants and meteorologic parameters in this study (Table 3) were consistent with the primary sources of the pollutants in the study region and established atmospheric chemical processes. The negative correlation between O3 and NO2 is in keeping with the process of nitric oxide scavenging O3 in the atmosphere and the photodissociation of NO2 to nitric oxide and O3. The correlation among CO, SO2, and NO2 suggests traffic as the common source. This premise is also supported by the fact that the hour-of-day effect for each pollutant peaked in the mornings and, to a lesser extent, the afternoons and the day-of-week effect showed a drop on weekends.

23The literature documents pollutant-associated elevations in pulmonary IL-6 in healthy subjects (in vivo) and tissue (in vitro). Elevations in systemic IL-6 with elevated PM pollution have also been found in subjects with preexisting chronic inflammatory conditions. Our study adds to the conclusion that pollution may increase systemic inflammation even in young healthy subjects. In young people, beyond the acute subclinical effects, recurrent low-grade acute inflammatory responses to pollution may ultimately have implications for the evolution of atherosclerosis and other processes influenced by inflammation.

24Fibrinogen was not significantly associated with any of the pollutants considered in this investigation. It may be that ambient levels of PM2.5 in this study were too low to induce a significant effect. This hypothesis is supported by the literature, which has reported no significant association between ambient pollution and fibrinogen at low levels of exposure but significant associations with high exposures such as during high air pollution episodes or controlled human exposure studies.

25In our study of young healthy subjects, we found that cumulative exposure to pollution over longer periods of time (3–6 days) was associated with the strongest associations with elevated IL-6. In elderly subjects with diabetes or obesity, longer cumulative averages also resulted in the greatest effects on inflammation in a study of PM2.5 effects on CRP, IL-6, and white blood cells. found an increase in IL-6 associated with particle number concentration, with a shorter lag of 12–17 hr. It may be that because all of our blood draws took place at 1000 hours, the 2- to 12-hr moving averages represent times when most subjects were in their homes; this may have attenuated the more immediate effects of outdoor pollution levels. Alternatively, at these levels of pollution, a longer cumulative exposure may be needed for this inflammatory response.

26A limitation of this study was the small sample size, which limited power to test for interactions. Additional limitations include the absence of indoor home monitoring and the use of fixed-site ambient pollution monitoring, which may result in exposure misclassification, particularly for ambient pollutants that have strong local sources. Each of these limitations would be expected to bias the results toward the null. Although we found that the association of many of the pollutants with elevated IL-6 was greater in the summer, correlation among the pollutants and limited numbers of observations made it difficult to evaluate which of the pollutants, or which mixture of pollutants, was leading to the increased inflammatory response. We could not confirm the associations of ambient pollution with inflammation by using additional complementary end points (e.g., CRP, tumor necrosis factor-α). We are able to describe relative but not absolute changes of IL-6 levels in response to pollution because we transformed the data to Z-scores in order to combine data from two separate studies.

27The potential implications of the findings of this study extend beyond demonstrating that ambient pollutant exposure has a significant effect on baseline systemic levels of IL-6. Knowledge regarding the effect of prior ambient pollution exposure in baseline evaluation of systemic inflammation in human chamber exposure studies is important for interpretation of the results of such studies., using in vitro studies, demonstrated that “priming” of lung epithelial cells with inflammatory mediators before exposure to fine CAPs resulted in a greater inflammatory response. By analogy, priming of baseline inflammatory status by prior ambient air pollution exposure could modify the response of human subjects to controlled pollutant exposure in chamber studies. Such effect modification could lead to nondifferential misclassification bias (trials are conducted in random order), resulting in an underestimation of the true effect that pollutant exposure has on the induction of inflammation in humans.

28Alternatively, ambient pollution could potentially prime and amplify the response to exposure in the chamber. A third possibility is that adaptation through ambient exposures to pollution could dampen certain immunologic or physiologic responses to acute chamber exposures. Finally, if prior exposure to ambient pollution were to equally affect pre- and postexposure measurements, then there would be much less concern about taking prior exposures to ambient pollutants into effect when doing controlled exposure studies. Investigation of the effects of cumulative ambient exposures to pollutants on responses to controlled human chamber exposure to pollutants will help in the interpretation of these studies.

29Our results support previous findings of an association between ambient pollution and IL-6. In our analysis, exposure to ambient levels of O3 and SO2 was positively and significantly associated with a systemic inflammatory response as measured by systemic levels of IL-6. The association between IL-6 and O3 and SO2 demonstrated a cumulative lag effect with the strongest effects observed using 3- to 5-day moving averages. Pollution effects varied by season. Fibrinogen levels were not correlated with any of the investigated pollutants. Having demonstrated an effect of ambient pollutant exposure on baseline systemic levels of IL-6, future research should focus on whether ambient pollution exposure modifies the effect of inflammatory responses to controlled pollution exposures human chamber studies.